New treatment strategies for aggressive lymphoma
- 31 December 2004
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 31, 10-13
- https://doi.org/10.1053/j.seminoncol.2004.11.022
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHLBlood, 2004
- Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHLBlood, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphomaBlood, 2003
- Doxorubicin‐based chemotherapy for diffuse large B‐cell lymphoma in elderly patientsCancer, 2003
- Dose-Intense Chemotherapy Every 2 Weeks With Dose-Intense Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone May Improve Survival in Intermediate- and High-Grade Lymphoma: A Phase II Study of the Southwest Oncology Group (SWOG 9349)Journal of Clinical Oncology, 2003
- Delivery of Full Dose CHOP Chemotherapy to Elderly Patients with Aggressive Non-Hodgkin's Lymphoma without G-CSF SupportLeukemia & Lymphoma, 1999
- A Phase II Trial of Prednisone, Oral Etoposide, and Novantrone (PEN) as Initial Treatment of Non-Hodgkin's Lymphoma in Elderly PatientsLeukemia & Lymphoma, 1995
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Survival of diffuse large cell lymphoma. A multivariate analysis including dose intensity variablesCancer, 1990